FDA News Roundup: Merck, UCB, Pfizer, Ipsen, And More

In the news this week, the FDA recently approved the first immunotherapy for melanoma, as well as drugs for epilepsy and myelodysplastic syndrome. The FDA also cleared several drugs for new indications, QIDP status, and orphan drug status.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news